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ABSTRACT	
Background:	The	 first	 publication	 that	 associated	Human	Papillomavirus	 (HPV)	 infection	 and	
esophageal	 cancer	was	 published	 in	 1982.	However,	 data	 are	 still	 contradictory	 and	 require	
further	 investigation.	 The	aim	of	 this	 study	was	 to	 identify	high	 risk	HPV	DNA	 in	esophageal	
tissue	of	patients	with	and	without	esophageal	squamous	cell	carcinoma	(ESCC)	and	correlate	
HPV	 presence	 with	 classical	 risk	 factors.	 Methods:	 Invited	 patients	 signed	 the	 informed	
consent	 form,	 and	 interviews	 were	 conducted	 in	 order	 to	 obtain	 information	 about	
sociodemographic	 and	 lifestyle	 behavior.	 During	 endoscopy,	 esophageal	 biopsies	 were	
collected	 from	 case	 and	 controls.	 Multiplex	 polymerase	 chain	 reaction	 genotyping	 was	
conducted	on	endoscopic	biopsies	to	identify	HPV	types	and	HPV-16	was	further	evaluated	by	
specific	 PCR	 real	 time.	Results:	Among	 87	 cases,	 12	 (13.8%)	 had	 tumors	 harboring	 high	 risk	
HPV	 DNA	 and	 among	 87	 controls,	 12	 (13.8%)	 had	 high	 risk	 HPV	 DNA	 (OR:1.025	
[CI:0.405:2.592]).	Variables	regarding	consumption	of	alcohol	and	use	of	tobacco	continued	to	
characterize	 risk	 factors	 even	 after	 adjustments	 by	 presence	 or	 absence	 of	 high	 risk	 HPV.	
Conclusion:	HPV	was	demonstrated	 to	be	 frequently	 and	 similarly	 associated	 to	normal	 and	
malignant	 esophageal	 tissues,	 but	 not	 as	 an	 independent	 risk	 factor	 to	 esophageal	 cancer.	
Impact:	 To	 contribute	 to	 the	 Brazilian	 population	 data	 on	 this	 subject,	 which	 is	 still	
contradictory.	
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INTRODUCTION	
Currently,	 esophageal	 cancer	 (EC)	 is	 an	 important	 public	 health	 problem	 worldwide.	
According	to	estimates	by	GLOBOCAN	2012,	EC	is	the	eighth	most	common	cancer	worldwide	
and	the	sixth	most	common	cause	of	cancer	death	(Ferlay	et	al.,	2013).	
Risk	factors	related	to,	and	those	suspected	of	being	involved	with	EC,	have	been	widely	
studied;	however,	 little	has	been	achieved	since	the	classic	studies	of	Wynder	et	al.	 (Wynder	
and	 Bross,	 1961)	 and	 Silber	 (Silber,	 1985),	 suggesting	 an	 association	 of	 some	 chemicals	
(nitrosamines,	 mycotoxins,	 cigarette	 smoke,	 excessive	 intake	 of	 alcohol	 and	 opium	 abuse),	
physical	 (solid	 and	 hot	 food)	 and	 nutritional	 deficiencies	 (particularly	 vitamins	 A,	 B,	 C	 and	
certain	trace	elements	such	as	molybdenum	and	zinc)	with	the	development	of	this	malignant	
neoplasm	(Wynder	and	Bross,	1961;	Silber,	1985).	
Recently,	 evidence	 suggests	 that	 human	 papillomavirus	 (HPV)	may	 play	 an	 etiological	
role	 in	 esophageal	 carcinogenesis,	 in	 at	 least	 one	 subtype	 of	 esophageal	 carcinoma,	 the	
squamous	 cell	 carcinoma;	 the	 number	 of	 studies	 in	 this	 area	 have	 increased	 steadily,	 as	
evidenced	 in	 several	 reviews	 (Syrjanen,	 1987;	 Syrjänen	 et	 al.,	 1996;	 Syrjanen,	 2000a,b;	
Syrjanen	2002;	Syrjänen,	2003).	The	first	descriptions	of	oral	lesions	associated	with	HPV	were	
preceded	by	reports	that	suggested	the	involvement	of	viruses	in	the	development	of	benign	
(Syrjanen	et	al.,	1982)	and	malignant	(Syrjanen,	1982)	 lesions	of	the	squamous	epithelium	of	
the	 esophagus.	 These	 initial	 observations	 were	 based	 on	 the	 discovery	 of	 morphological	
similarities	 between	 HPV	 lesions	 in	 the	 genital	 tract	 (warts)	 and	 esophageal	 lesions	
(papillomas)	(Syrjanen	et	al.,	1982;	Syrjanen,	1982).	
Althogh	the	first	report	on	the	presence	of	HPV	in	esophageal	squamous	cell	carcinoma	
(ESCC)	occurred	more	than	30	years	ago	(Syrjanen	et	al.,	1982),	its	real	prevalence	is	still	poorly	
known	 and	 its	 role	 in	 carcinogenesis	 is	 questionable.	 Although	 the	 number	 of	 studies	 and	
interest	in	the	subject	have	increased	in	recent	years,	the	literature	is	scarce	and	controversial	
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(Kamangar	 et	 al.,	 2009).	 Data	 accumulated	 reflects	 a	 trend	 linking	 HPV	 and	 EC	 in	 high	 risk	
areas,	whereas	in	low	risk	areas	such	association	was	not	evident	(Antunes	et	al.,	2013).	
Knowing	that	esophageal	carcinogenesis	is	complex,	dependent	on	different	risk	factors	
and	 considering	 the	 controversial	 results	 described	 in	 reports	 that	 correlate	 high	 risk	 HPV	
infection	with	 the	development	of	 ESCC,	we	 aimed,	 in	 this	 study,	 to	 characterize	 individuals	
without	cancer	and	patients	with	ESCC	 in	 relation	 to	 the	presence	of	high	risk	HPV	DNA	and	
well	known	risk	factors	for	both	EC	as	well	as	for	HPV	infection.	
	
MATERIALS	AND	METHODS	
	 This	 is	 an	 observational	 case-control	 study.	 Cases	 were	 defined	 as	 patients	 of	 both	
genders,	aged	above	18	years,	who	were	admitted	to	the	Barretos	Cancer	Hospital	(BCH),	with	
histopathological	 confirmation	 of	 ESCC,	 clinical	 indication	 for	 endoscopy	 and	 no	 previous	
treatment	 for	cancer.	Controls	were	defined	as	 individuals	without	cancer	of	 the	esophagus,	
having	 had	 clinical	 indication	 for	 endoscopy	 for	 benign	 disease	 of	 the	 digestive	 system,	
examined	in	the	Endoscopy	Department	from	Medical	Specialties	Ambulatory	(AME,	acronym	
in	 Portuguese)	 in	 Barretos,	 São	 Paulo,	 Brazil.	 The	 sample	 size	 of	 that	 prospective	 and	
controlled	study	was	based	on	earlier	published	work	(Guo	et	al.,	2012).	Patients	with	limited	
understanding	 of	 research	 objectives	 during	 the	 consent,	 submitted	 to	 adjuvant	 and/or	
neoadjuvant	 therapy	 previous	 to	 sample	 collection,	 mental	 disability,	 unfavorable	 clinical	
conditions	 to	 undergo	 medical	 procedures,	 or	 insufficient	 amount	 of	 sample	 and/or	
inadequate	quality	were	excluded.	
	
• Endoscopic	examination	and	sample	collection	
The	 procedure	 for	 conducting	 the	 Digestive	 Endoscopy	 followed	 the	 routine	 of	 the	
Department	 of	 Endoscopy	 at	 BCH	 and	 Ambulatory	 Medical	 Specialties	 in	 Barretos,	 using	
sedation	 and	 flexible	 video	 endoscopes	 (Olympus	 180,	 Japan;	 Fuginon	 4400,	 Japan).	 The	
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collection	 of	 biological	 samples	 was	 prospectively	 performed	 from	 esophageal	 biopsies.	
Samples	 were	 fixed	 in	 formalin	 and	 embedded	 in	 paraffin.	 The	 biological	 material	 was	
processed	by	the	Department	of	Pathology,	at	BCH	for	histopathological	diagnosis.		
	
• HPV	detection	and	characterization	
Specimens	 were	 digested	 with	 proteinase	 K-SDS	 1%	 and	 HPV	 DNA	 was	 obtained	 by	
organic	extraction	(Green	and	Sambrook,	2012).	HPV	DNA	was	measured	in	all	samples	using	
type-specific	 PCR	 bead-based	multiplex	 genotyping	 (TS-MPG)	 assays	 that	 combine	multiplex	
polymerase	chain	reaction	(PCR)	and	bead	based	Luminex	technology	(Luminex	Corp.,	Austin,	
TX,	USA),	as	described	elsewhere	(Nunes	et	al.,	2016).	This	methodology	is	able	to	identify	21	
HPV	 types	 including	 13	 of	 high-risk	 and	 3	 of	 low	 risk	 oncogenic,	 accordingly	 (Munoz	 et	 al.,	
2006;	Gheit	et	al.,	2007).		
As	a	positive	control	for	the	quality	of	the	template	DNA,	primers	targeting	the	β-globin	
gene	were	included.	The	assays	were	performed	with	10µL	DNA	template	in	a	96-well	format	
in	25-μl/well	reaction	volume.	HPV	multiplex	PCR	was	performed	with	QIAGEN	Multiplex	PCR	
Kit	 (Qiagen,	 Dusseldorf,	 Germany),	 according	 to	 manufacturer’s	 instructions.	 Each	 reaction	
consisted	of	45	cycles:	94°C	for	30	seconds,	63°C	for	3	minutes,	and	72°C	for	90	seconds.	The	
first	cycle	was	preceded	by	incubation	at	95°C	for	15	minutes	and	the	last	one	was	extended	
for	10	minutes	at	72°C.	Negative	controls	consisted	of	reaction	mixture	without	DNA.	
The	hybridization	assay	was	performed	according	to	Schmitt	et	al.	(2006)	(Schmitt	et	al.,	
2006).	 For	 each	HPV	 type-specific	 probe,	mean	 fluorescence	 intensity	 (MFI)	 values	 obtained	
when	 no	 PCR	 product	 was	 added	 to	 the	 mixture	 of	 hybridization,	 was	 considered	 as	
background.	The	cutoff	was	calculated	by	adding	5	MFI	 for	1.1	X	the	value	of	median	found.	
We	considered	positive	values	higher	than	20	MFI.	
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• Statistical	analyses	
Covariates	 associated	with	HPV	detection	 and	 ESCC	were	 analyzed	 and	 the	 results	were	
expressed	as	odds	ratio	(OR)	by	simple	logistic	regression.	Confirmatory	model	were	analyzed	
in	 multiple	 logistic	 regression	 between	 alcohol	 and	 tobacco	 interaction,	 where	 time	 and	
consumption	were	considered,	using	the	HPV	detection	as	variable	of	interest.	The	respective	
intervals	with	95%	confidence	 (95%	CI)	were	also	presented.	 The	 significance	 level	was	0.05	
(5%).	For	tabulation	and	statistical	analysis	we	used	IBM®	SPSS®	Statistics	20.0.1	software	for	
Windows	(IBM	Corporation,	Route	100,	Somers	NY	10589).	
	
RESULTS	
During	 the	 period	 between	 February	 2013	 and	 August	 2014,	 174	 individuals	 were	
enrolled,	of	which	87	(50.0%)	were	patients	with	ESCC	(cases)	and	87	(50.0	%)	was	individuals	
without	cancer	(controls).	Cases	and	controls	were	matched	(1	case	:	1	control)	by	gender	and	
age	(±	3	years).	The	population	of	the	study	had	the	following	characteristics:	male	(78.2%;	n	=	
136),	 self-reported	white	 skin	 (67.9%;	n	=	110);	marital	 status	 (69.5%;	n	=	121);	 low	 level	of	
schooling	(16.7%	n	=	29)	were	illiterate	and	71.3%	(n	=	124)	attended	up	to	middle	school.	Age	
ranged	from	41-83	years	(mean	=	60.6	years,	SD	=	10.1	years;	median	=	60.0	years).		
Table	 1	 shows	 the	 results	 of	 the	 comparison	 between	 cases	 and	 controls	 by	 high	 risk	
HPV	 DNA,	 correlated	 with	 social	 status,	 consumption	 of	 alcohol,	 tobacco	 and	 sexual	 habits	
variables.	
Regarding	the	combined	effect	of	tobacco	use	and	alcohol	consumption	over	the	course	
of	time,	individuals	who	consumed	alcohol	for	less	than	15	years	and	tobacco	for	more	than	15	
years	had	9.6	fold	increased	risk	to	develop	ESCC	relative	to	those	who	consumed	alcohol	and	
tobacco	 for	 less	 than	 15	 years;	 individuals	 who	 consumed	 alcohol	 more	 than	 15	 years	 and	
tobacco	for	 less	than	15	years	had	a	5.5	fold	increased	risk	to	develop	ESCC	relative	to	those	
who	consumed	alcohol	and	tobacco	less	than	15	years;	individuals	who	consumed	alcohol	and	
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tobacco	for	more	than	15	years	had	a	10.4	fold	increased	risk	to	develop	ESCC	relative	to	those	
who	consumed	alcohol	and	tobacco	for	less	than	15	years	(Table	1).	
There	 was	 no	 statistically	 significant	 difference	 between	 the	 variables	 age	 at	 first	
intercourse	 and	 number	 of	 partners	 (Table	 1).	 Active	 oral	 sexual	 intercourse	 showed	
statistically	 significant	 differences	 (p	 =	 0.017).	 Individuals	who	 reported	 engaging	 in	 oral	 sex	
once	 in	 their	 lives	had	a	 lower	 risk	 (OR	=	0.4)	of	having	ESCC	when	compared	 to	 individuals	
who	reported	never	having	performed	oral	sex	(Table	1).	
In	 the	 multivariate	 analysis,	 using	 a	 confirmatory	 model	 including	 the	 Interaction	 of	
tobacco	and	alcohol,	considering	time	and	consumption,	and	included	the	HPV	detection	with	
interest	 variable,	 the	 HPV	 didn’t	 show	 an	 increased	 risk	 to	 ESCC.	 The	 results	 of	 the	
multivariable	regression	analyses	are	shown	in	Table	2.		
		
	
DISCUSSION	
The	 results	 herein	 reported	 revealed	 a	 high	 prevalence	 of	 high	 risk	 HPV	 DNA	 in	
esophageal	 mucosa;	 however,	 these	 occurrences	 did	 not	 seem	 to	 have	 the	 same	 causality	
observed	 in	 cervix	 carcinoma.	 This	 data	 is	 very	 interesting	 and	 intriguing	 because	 they	
stimulate	 provocative	 queries	 about	 the	 behavior	 of	 high	 risk	 HPV	 DNA	 in	 the	 esophageal	
tissue.	Different	 risk	 factors	were	evaluated,	 especially	 those	widely	 known	 to	 facilitate	HPV	
infection.	History	of	oral	sexual	intercourse,	e.g.,	was	not	a	discriminatory	variable,	indicating	
that	for	cases	and	controls,	the	presence	of	high	risk	HPV	DNA	can	be	a	constant	independent	
of	 the	 meaning	 of	 any	 injury.	 On	 the	 contrary,	 it	 was	 observed	 that	 alcohol	 and	 tobacco	
consumption	still	prevail	as	the	classic	risk	factors	for	developing	ESCC.	
This	was	 an	observational	 case-control	 study;	 such	a	design	 is	 generally	 used	 for	 slow	
progressive	disease	and	allows	the	evaluation	of	various	risk	factors	for	a	particular	outcome	
(Cousens	 and	 Balthazar	 1995).	 However,	 these	 studies	 are	 subject	 to	 criticism	 because	 they	
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may	contain	limitations	as	related	to	the	control	group	selection	and	also	the	interpretation	of	
the	results	may	be	hampered	by	confounding	factors	(Pereira,	1995).	
Selection	 of	 participants	 for	 the	 “case”	 group	 was	 performed	 at	 the	 Endoscopy	
Department	of	the	BCH,	an	exclusively	specialized	oncology	center.	We	included	individuals	for	
the	 “control”	 group	 in	 the	 Endoscopy	 Department	 of	 the	 AME,	which	 is	 also	 located	 in	 the	
municipality	of	Barretos,	São	Paulo,	Brazil.	The	differences	between	the	general	characteristics	
of	the	two	groups	generate	results	that	cannot	be	sufficiently	explained	as	what	occurred	with	
oral	 sex	 intercourse,	 evaluated	 as	 a	 protector	 factor.	 In	 order	 to	 balance	 the	 divergence	
between	institutions	and	to	assemble	homogeneous	groups,	patients	were	matched	by	gender	
and	age	(±	3	years).	
Many	 studies	about	EC	achieved	data	 from	 retrospective	 cases	and	 	 scarcely	 reported	
information	about	the	population	characteristics	enrolled.	The	differential	of	the	current	work	
was	 the	 prospective	 collection	 of	 samples	 and	 detailed	 questionnaire	 	 about	 individual	
characteristics,	which	allows	for	the	rigorous	selection	of	the	biopsy	area	and	the	range	of	risk	
factors	 evaluated.	 Consequently,	 several	 reports	 worldwide	 have	 described	 heterogeneous	
data	regarding	HPV	prevalence	in	the	esophageal	tissue	that	varied	from	the	absence	of	virus	
(Ashworth	et	al.,	1993;	Rugge	et	al.,	1997;	Gao	et	al.,	2006;	Koh	et	al.,	2008;	Antunes	et	al.,	
2013),	to	prevalences	up	to	100%	(Li	et	al.,	2001)	in	ESCC.	In	control	population,	some	studies	
also	report	the	absence	of	the	virus	(Lenhart	et	al.,	1991;	Ashworth	et	al.,	1993;	Cooper	et	al.,	
1995;	 Fidalgo	 et	 al.,	 1995;	 Lambot	 et	 al.,	 2000;	 Souto	 Damin	 et	 al.,	 2006;	 Koh	 et	 al.,	 2008;	
Antonsson	 et	 al.,	 2010)	 and	 others	 reported	 prevalences	 as	 high	 as	 59%	 (Li	 et	 al.,	 2001).	 It	
should	 be	 considered	 that	 this	 variation	 in	 prevalence	 can	 be	 explained	 by	multiple	 factors	
such	as	the	methodological	differences	used	to	detect	HPV,	the	number	of	cases	analyzed,	as	
well	 as	 environmental,	 geographic	 and	 demographic	 differences	 among	 the	 populations	
evaluated	(Takahashi	et	al.,	1998;	Kawaguchi	et	al.	2000;	Matsha	et	al.,	2002;	Syrjanen,	2002;	
Far	et	al.,	2007;	Malik	et	al.,	2011;	Zhang	et	al.,	2011;	Syrjanen,	2013).	
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In	 the	Brazilian	 territory,	 the	 prevalence	of	HPV	 in	 ESCC	was	 analyzed	 in	 four	 studies,	
ranging	 from	0%	to	16%	(Weston	and	Prolla	2003;	Souto	Damin	et	al.,	2006;	Herbster	et	al.,	
2012;	 Antunes	 et	 al.,	 2013).	 Several	 studies,	 including	 those	 performed	 in	 Brazil,	 have	 in	
common	 the	 fact	 that	 these	were	 conducted	 retrospectively,	 performed	with	 different	 HPV	
detection	techniques	and	quite	conflicting	results.	All	the	data	supported	that	HPV,	somehow,	
is	 not	 involved	 with	 the	 esophagus	 carcinogenesis,	 which	 is	 corroborated,	 in	 part,	 by	 our	
findings.	Furthermore,	our	study	showed	the	same	positivity	indexes	for	high	risk	HPV	DNA,	in	
controls	and	cases,	also	observed	 in	other	 studies.	The	high	sensitivity	of	 the	methodologies	
herein	 used,	 and	 the	 strict	 control	 of	 prospectively	 collected	 samples,	 are	 determinant	
variables	 to	 explain	 these	 differences	 among	 the	 results	 observed	 in	 Brazilian	 regions.	 It	 is	
important	to	emphasize,	however,	that	 in	Brazil,	HPV-related	to	esophageal	cancer,	does	not	
have	the	same	meaning	as	reported	in	other	countries,	such	as	China,	for	example	(Guo	et	al.,	
2012).		
HPV	 prevalence	 observed	 among	 cases	 is	 high	 when	 compared	 to	 global	 data	
accumulated	so	far,	but	reflect	and	corroborate	the	results	described	in	many	studies	found	in	
the	 literature.	 Studies	 conducted	 in	 South	 Africa,	 India,	 Greece	 and	 Japan	 found	 similar	
prevalences	as	we	obtained,	ranging	from	15%	to	25%	(Williamson	et	al.,	1991;	Agarwal	et	al.,	
1998;	Khurshid	et	al.,	1998;	Lyronis	et	al.,	2005).	In	individuals	without	cancer,	however,	there	
is	 a	 higher	 prevalence	 rate	when	 compared	 only	 to	 data	 published	 in	 Brazilian	 literature	 to	
date	(Weston	and	Prolla,	2003;	Souto	Damin	et	al.,	2006;	Antunes	et	al.,	2013).	
It	 is	well-known	 that	 three	 forms	 of	 HPV	 infection	may	 occur:	 clinical,	 subclinical	 and	
latent.	 The	 latent	 virus	 can	 be	 diagnosed	 only	 by	 molecular	 techniques	 targeting	 HPV-DNA	
(Richart	 and	Wright,	 1991).	 Therefore,	 we	 hypothesize	 that	 this	 may	 be	 the	 form	 found	 in	
controls	 in	 this	 study.	 The	 mechanisms	 by	 which	 the	 HPV	 remains	 in	 this	 state	 of	 latency	
remain	 largely	 unknown,	 but	 it	 is	 believed	 that	 immunological	 factors	 are	 decisive	 for	 this	
condition.	Often,	HPV	infection	may	regress	spontaneously,	but	we	have	no	further	knowledge	
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about	how	long	the	virus	could	remain	in	this	state,	nor	about	the	rate	of	progression	of	this	
form	of	latency	(Burd,	2003).		
	 Alcohol	 consumption	 was	 considered	 a	 major	 risk	 factor	 for	 ESCC.	 The	 International	
Agency	for	Research	on	Cancer	(IARC)	classifies	alcohol	as	a	cause	of	esophageal	cancer	(IARC	
2008)	 and	 ecological	 and	 case-control	 classical	 studies	 established	 that	 alcohol	 has	 a	 strong	
causal	role	in	the	development	of	ESCC	in	most	regions	of	the	world	(Tuyns,	1970;	Audigier	et	
al.,	1975;	Tuyns	et	al.,	1979;	Tuyns,	1983).	Tobacco	use	was	also	considered	a	 risk	 factor	 for	
ESCC	in	this	study,	mainly	when	smoking	hand-rolled	cigarettes	was	considered	separately.	We	
can	also	observe	the	so	called	“dose	response	effect”,	in	that	the	risk	increased	as	the	amount	
consumed	also	increased.	
The	 difference	 between	 study	 groups	 engaged	 in	 active	 oral	 sex	 may	 be	 related	 to	
selection	bias	 of	 the	 control	 population.	As	much	 as	 has	 been	paired	by	 sex	 and	 age	 to	 the	
homogenization	 of	 the	 groups,	 it	 is	 observed	 that	 the	 control	 group	 is	 markedly	 more	
urbanized,	which,	despite	potential	controversies,	may	directly	reflect	the	data	on	the	sexual	
habits	obtained	in	this	study.	
HPV	was	demonstrated	to	be	frequently	associated	to	normal	and	malignant	esophageal	
tissues	despite	the	fact	that	esophageal	HPV	presence	does	not	appear	to	be		a	risk	factor	for	
ESCC	development,	esophagus	seems	to	be	an	important	HPV-reservoir,	in	health	or	disease.	
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List	of	abbreviations	
AME:	Medical	Specialties	Ambulatory	
BCH:	Barretos	Cancer	Hospital	
CI:	Confidence	Interval	
EC:	Esophageal	cancer	
ESCC:	Esophageal	squamous	cell	carcinoma	
HPV:	Human	papillomavirus		
OR:	Odds	Ratio	
PCR:	Polymerase	chain	reaction		
	
Ethical	Aspects	and	Consent	to	Participate	
This	 study	 was	 approved	 by	 the	 Ethics	 Committee	 at	 BCH	 	 with	 register	 number	 134471.	
Patients	 were	 referred	 to	 a	 private	 room	 and	 informed	 about	 the	 purpose	 of	 the	 study,	
procedures	 for	 biological	 sampling	 and	 the	 necessary	 information	 requested	 on	 the	 data	
collection	 instrument.	Patients	who	agreed	to	participate	signed	the	 Informed	Consent	form.	
Participants,	 then,	 answered	 a	 questionnaire	 containing	 sociodemographic	 information	 and	
explaining	the	known	risk	factors	for	the	HPV	infection	and	EC.	All	interviews	were	conducted	
by	 previously	 trained	 members	 of	 the	 HPV	 Research	 Group	 at	 BCH	 -	 Pius	 XII	 Foundation.	
Interviews	provided	information	to	characterize	the	duration	and	type	of	exposure.		
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Tables	
	
Table	1	–	Odds	ratio	associate	with	patients	characteristics	(n=	174)	
Variable	 Cases	 	 Controls	 	 OR	[95%	CI]	
Univariate	Category	 n	 %	 	 n	 %	 	
High	Risk	HPV	 	 	 	 	 	 	 	
Negative	 75	 86.2	 	 75	 86.2	 	 Reference	
Positive	 12	 13.8	 	 12	 13.8	 	 1.00	[0.42	:	2.36]		
Sociodemographic	variables	
Sex	 	 	 	 	 	 	 	
Female	 19	 21.8	 	 19	 21.8	 	 Reference	
Male	 68	 78.2	 	 68	 78.2	 	 1.00	[0.48	:	2.05]	
Age		 	 	 	 	 	 	 	
≤	60	years	 46	 52.9	 	 42	 48.3	 	 Reference	
>	60	years	 41	 47.1	 	 45	 51.7	 	 0.82	[0.45	:	1.51]	
Race	(self-reported)	*	 	 	 	 	 	 	 	
White	 59	 71.1	 	 51	 64.6	 	 Reference	
Non-white	 24	 28.9	 	 28	 35.4	 	 0.74	[0.37	:	1.44]	
Marital	status	 	 	 	 	 	 	 	
Not	married	 33	 37.9	 	 20	 23.0	 	 Reference	
Married	 54	 62.1	 	 67	 77.0	 	 0.48	[0.25	:	0.94]	
Education	 	 	 	 	 	 	 	
Illiterate	 15	 17.2	 	 14	 16.1	 	 Reference	
Up	to	middle	school	 63	 72.4	 	 61	 70.1	 	 0.96	[0.42	:	2.16]	
High	school	/	Graduate	 9	 10.3	 	 12	 13.8	 	 0.70	[	0.22	:	2.16]	
Life	Habits	
Interaction	time	consumption	of	tobacco	and	alcohol		
Alcohol	<15	years	and	Tobacco	<15	years	 3	 3.4	 	 21	 24.1	 	 Reference	
Alcohol	<15	years	and	Tobacco	≥15	years	 11	 12.6	 	 8	 9.2	 	 9.6	[2.11	:	43.75]	
Alcohol	≥15	years	and	Tobacco	<15	years	 15	 17.2	 	 19	 21.8	 	 5.52	[1.38	:	22.10]	
Alcohol	≥15	years	and	Tobacco	≥15	years	 58	 66.7	 	 39	 44.8	 	 10.40	[2.9	:	37.29]	
Interaction	consumption	of	tobacco	and	alcohol	*	
Alcohol	<30	g	alcohol/day	and	Tobacco	<40	packs/year	 57	 66.3	 	 67	 77.9	 	 Reference	
Alcohol	<30	g	alcohol/day	and	Tobacco	≥40	packs/year		 12	 14.0	 	 6	 7.0	 	 2.35	[0.83	:	6.66]	
Alcohol	≥30	g	alcohol/day	and	Tobacco	<40	packs/year	 11	 12.8	 	 10	 11.6	 	 1.29	[0.51	:	3.26]	
Alcohol	≥30	g	alcohol/day	and	Tobacco	≥40	packs/year	 6	 7.0	 	 3	 3.5	 	 2.35	[0.56	:	9.82]	
Sexual	habits	
Age	at	first	intercourse	*	 	 	 	 	 	
≤15	years	old	 29	 34.9	 	 25	 29.1	 	 Reference	
>15	-	≤17	years	old	 21	 25.3	 	 22	 25.6	 	 0.79	[0.35	:	1.79]	
>17	years	old	 33	 39.8	 	 39	 45.3	 	 0.71	[0.35	:	1.46]	
Partner	number	*	 	 	 	 	 	 	 	
<=	5	 34	 41.0	 	 44	 50.6	 	 Reference	
>	5	 49	 59.0	 	 43	 49.4	 	 1.47	[0.80	:	2.70]	
Total	 87	 100	 	 87	 100	 	 	
*	There	are	missing	values.	
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Table	2	–	Multivariable	analyses	
Variable	 p	 	 OR	[95%	CI]	Univariate	Category	 	
High	Risk	HPV	 	 	 	
Negative	 0.959	 	 Reference	
Positive	 	 	 1.025	[0.405	:	2.592]	
Interaction	time	consumption	of	tobacco	and	alcohol		
Alcohol	<15	years	and	Tobacco	<15	years	 0.007	 	 Reference	
Alcohol	<15	years	and	Tobacco	≥15	years	 0.005	 	 9.423	[1.974	:	44.981]	
Alcohol	≥15	years	and	Tobacco	<15	years	 0.016	 	 5.572	[1.372	:	22.627]	
Alcohol	≥15	years	and	Tobacco	≥15	years	 0.001	 	 9.581	[2.592	:	35.421]	
Interaction	consumption	of	tobacco	and	alcohol	*	
Alcohol	<30	g	Alcohol/day	and	Tobacco	<40	packs/year	 0.866	 	 Reference	
Alcohol	<30	g	Alcohol/day	and	Tobacco	≥40	packs/year		 0.489	 	 1.468	[0.495	:	4.355]	
Alcohol	≥	g	Alcohol/day	and	Tobacco	<40	packs/year	 0.890	 	 0.935	[0.358	:	2.441]	
Alcohol	≥	g	Alcohol/day	and	Tobacco	≥40	packs/year	 0.614	 	 1.460	[0.335	:	6.359]	
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